|
1DUJ
SOLUTION STRUCTURE OF THE SPINDLE ASSEMBLY CHECKPOINT PROTEIN HUMAN MAD2
Deposited 2000-01-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
11–195(185 aa)
Fragment:FULL PROTEIN WITHOUT BOTH N- AND C-TERMINAL 10 RESIDUES
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 300mM KCl;Pressure ambient
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 300mM KCl;Pressure ambient
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 300mM KCl;Pressure ambient
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 300mM KCl;Pressure ambient
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 300mM KCl;Pressure ambient
NMR sample composition
1.2mM Mad2 protein U-15N,13C,2H; 50mM sodium phosphate (pH 6.8), 300mM KCl, 5mM DTT, 0.04% NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1.4mM Mad2 protein U-15N,13C; U-60% 2H; 50mM sodium phosphate (pH 6.8), 300mM KCl, 5mM DTT, 0.04% NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1.5mM Mad2 protein U-15N; 50mM sodium phosphate (pH 6.8), 300mM KCl, 5mM DTT, 0.04% NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1.6mM Mad2 protein U-10% 13C; 50mM sodium phosphate (pH 6.8), 300mM KCl, 5mM DTT, 0.04% NaN3; 100% D2O | 100% D2O
NMR sample composition
1.7mM Mad2 protein U-15N,13C; 50mM sodium phosphate (pH 6.8), 300mM KCl, 5mM DTT, 0.04% NaN3; 100% D2O | 100% D2O
|
Resolution not provided
|
|
1GO4
Crystal structure of Mad1-Mad2 reveals a conserved Mad2 binding motif in Mad1 and Cdc20.
Deposited 2001-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain A
1–205(205 aa)
Chain B
1–205(205 aa)
Chain C
1–205(205 aa)
Chain D
1–205(205 aa)
|
Mutation:R133A
Mutation:R133A
Mutation:R133A
Mutation:R133A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.2;PROTEIN CONCENTRATION 7.5 MG/ML HANGING DROP METHOD, WELL=100 MM AMMONIUM SULPHATE, 100 MM AMMONIUM CITRATE PH 5.2, 10 MM DTT
|
Resolution 2.05 Å
R-free 0.268
|
|
1KLQ
The Mad2 Spindle Checkpoint Protein Undergoes Similar Major Conformational Changes upon Binding to Either Mad1 or Cdc20
Deposited 2001-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
9–205(197 aa)
Fragment:MISSING N-TERMINAL 10 RESIDUES
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;303 K;Ionic strength (raw mmCIF value) 0.3M KCl;Pressure ambient
NMR measurement conditions
pH 7.4;303 K;Ionic strength (raw mmCIF value) 0.3M KCl;Pressure ambient
NMR measurement conditions
pH 7.4;303 K;Ionic strength (raw mmCIF value) 0.3M KCl;Pressure ambient
NMR measurement conditions
pH 7.4;303 K;Ionic strength (raw mmCIF value) 0.3M KCl;Pressure ambient
NMR measurement conditions
pH 7.4;303 K;Ionic strength (raw mmCIF value) 0.3M KCl;Pressure ambient
NMR measurement conditions
pH 7.4;303 K;Ionic strength (raw mmCIF value) 0.3M KCl;Pressure ambient
NMR sample composition
0.8mM Mad2 protein U-15N; 1mM MBP1 NA;
50mM phosphate buffer; 0.3M KCl;
1mM DTT | 90% H2O/10% D2O
NMR sample composition
0.8mM Mad2 protein U-15N, 13C, 2H; 1mM MBP1 NA;
50mM phosphate buffer; 0.3M KCl;
1mM DTT | 90% H2O/10% D2O
NMR sample composition
0.8mM Mad2 protein U-15N, 13C; 1mM MBP1 NA;
50mM phosphate buffer; 0.3M KCl;
1mM DTT | 90% H2O/10% D2O
NMR sample composition
0.8mM Mad2 protein U-15N, 13C, U-60% 2H; 1mM MBP1 NA;
50mM phosphate buffer; 0.3M KCl;
1mM DTT | 90% H2O/10% D2O
NMR sample composition
0.8mM MBP1 U-15N; 1mM Mad2 protein NA;
50mM phosphate buffer; 0.3M KCl;
1mM DTT | 90% H2O/10% D2O
NMR sample composition
0.8mM MBP1 U-15N, 13C; 1mM Mad2 protein NA;
50mM phosphate buffer; 0.3M KCl;
1mM DTT | 90% H2O/10% D2O
|
Resolution not provided
|
|
1S2H
The Mad2 spindle checkpoint protein possesses two distinct natively folded states
Deposited 2004-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–205(205 aa)
|
Mutation:R133A
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.8;303 K;Ionic strength (raw mmCIF value) 0.3M KCl;Pressure ambient
NMR sample composition
0.8mM Mad2 protein U-15N,13C,2H | 90% H2O, 10% D2O; 50mM phosphate buffer;
0.3M KCl; 1mM DTT
NMR sample composition
0.8mM Mad2 protein U-15N | 90% H2O, 10% D2O; 50mM phosphate buffer;
0.3M KCl; 1mM DTT
NMR sample composition
0.8mM Mad2 protein U-15N,13C | 90% H2O, 10% D2O; 50mM phosphate buffer;
0.3M KCl; 1mM DTT
|
Resolution not provided
|
|
2QYF
Crystal structure of the Mad2/p31(comet)/Mad2-binding peptide ternary complex
Deposited 2007-08-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–205(205 aa)
|
Mutation:L13A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;289 K;16% (w/v) PEG 3350, 16% (v/v) glycerol, 125 mM sodium phosphate (pH 5.0), 100 mM NaCl, 25 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å
R-free 0.257
|
|
2QYF
Crystal structure of the Mad2/p31(comet)/Mad2-binding peptide ternary complex
Deposited 2007-08-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–205(205 aa)
|
Mutation:L13A
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;289 K;16% (w/v) PEG 3350, 16% (v/v) glycerol, 125 mM sodium phosphate (pH 5.0), 100 mM NaCl, 25 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 2.30 Å
R-free 0.257
|
|
2V64
Crystallographic structure of the conformational dimer of the Spindle Assembly Checkpoint protein Mad2.
Deposited 2007-07-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
2–205(204 aa)
Fragment:RESIDUES 2-205
Chain E
2–108(107 aa)
Fragment:RESIDUES 2-108,118-205
Chain E
118–205(88 aa)
Fragment:RESIDUES 2-108,118-205
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;0.1M NAACETATE PH 4.6, 3.5M NAFORMATE
|
Resolution 2.90 Å
R-free 0.273
|
|
2V64
Crystallographic structure of the conformational dimer of the Spindle Assembly Checkpoint protein Mad2.
Deposited 2007-07-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
2–205(204 aa)
Fragment:RESIDUES 2-205
Chain D
2–108(107 aa)
Fragment:RESIDUES 2-108,118-205
Chain D
118–205(88 aa)
Fragment:RESIDUES 2-108,118-205
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;0.1M NAACETATE PH 4.6, 3.5M NAFORMATE
|
Resolution 2.90 Å
R-free 0.273
|
|
2V64
Crystallographic structure of the conformational dimer of the Spindle Assembly Checkpoint protein Mad2.
Deposited 2007-07-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
2–205(204 aa)
Fragment:RESIDUES 2-205
Chain H
2–108(107 aa)
Fragment:RESIDUES 2-108,118-205
Chain H
118–205(88 aa)
Fragment:RESIDUES 2-108,118-205
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;0.1M NAACETATE PH 4.6, 3.5M NAFORMATE
|
Resolution 2.90 Å
R-free 0.273
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–205(205 aa)
|
Mutation:YES
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 3
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 10
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain J
1–205(205 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 11
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain K
1–205(205 aa)
|
Mutation:YES
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 2
PE3 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 12
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain L
1–205(205 aa)
|
Mutation:YES
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 3
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–205(205 aa)
|
Mutation:YES
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 4
PE3 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–205(205 aa)
|
Mutation:YES
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 3
PE3 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–205(205 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
1–205(205 aa)
|
Mutation:YES
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 5
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain F
1–205(205 aa)
|
Mutation:YES
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 2
PE3 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain G
1–205(205 aa)
|
Mutation:YES
|
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 1
PE3 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain H
1–205(205 aa)
|
Mutation:YES
|
PE3 3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENTETRACONTANE-1,41-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
2VFX
Structure of the Symmetric Mad2 Dimer
Deposited 2007-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 9
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain I
1–205(205 aa)
|
Mutation:YES
|
CL CHLORIDE ION × 4
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;VAPOR DIFFUSION, HANGING DROP, 20 DEGREES C. 1 MICROLITER PROTEIN: 3 MG/ML IN 20 MM TRIS, PH 8.0, 50 MM NACL, 2 MM TCEP PLUS 1 MICROLITER RESERVOIR: 19% PEG2000, 16% GLYCEROL, 100 MM TRIS, PH 8.0, 0.3 M MGCL2
|
Resolution 1.95 Å
R-free 0.247
|
|
5KHU
Model of human Anaphase-promoting complex/Cyclosome (APC15 deletion mutant), in complex with the Mitotic checkpoint complex (APC/C-CDC20-MCC) based on cryo EM data at 4.8 Angstrom resolution
Deposited 2016-06-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 23
PDB declaration: 23-meric
|
Chain T
1–205(205 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.80 Å
|
|
5LCW
Cryo-EM structure of the Anaphase-promoting complex/Cyclosome, in complex with the Mitotic checkpoint complex (APC/C-MCC) at 4.2 angstrom resolution
Deposited 2016-06-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 23
PDB declaration: 23-meric
|
Chain Z
1–205(205 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.20 Å
|
|
6F0X
Cryo-EM structure of TRIP13 in complex with ATP gamma S, p31comet, C-Mad2 and Cdc20
Deposited 2017-11-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain Z
1–205(205 aa)
|
Not recorded
|
AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.60 Å
|
|
6TLJ
Cryo-EM structure of the Anaphase-promoting complex/Cyclosome, in complex with the Mitotic checkpoint complex (APC/C-MCC) at 3.8 angstrom resolution
Deposited 2019-12-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 23
PDB declaration: 23-meric
|
Chain Z
1–205(205 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.80 Å
|